Biophys J, March 2002, p. 1319-1328, Vol. 82, No. 3

Imperatoxin A Enhances Ca²⁺ Release in Developing Skeletal Muscle Containing Ryanodine Receptor Type 3

Thomas Nabhani,^* Xinsheng Zhu, Ilenia Simeoni, Vincenzo Sorrentino,^§ Héctor H. Valdivia, and Jesús García^*

 ^*Department of Physiology and Biophysics, University of Illinois at Chicago College of Medicine, Chicago, Illinois 60607, USA,  Department of Physiology, University of Wisconsin at Madison, Madison, Wisconsin, USA,  Molecular Medicine Section, Department of Neuroscience, University of Siena, Siena, Italy, and  ^§Dipartmento di Ricerca Biologica e Tecnologica, Istituto Scientifico San Raffaele, Milano, Italy

Most adult mammalian skeletal muscles contain only one isoform of ryanodine receptor (RyR1), whereas neonatal muscles contain two isoforms (RyR1 and RyR3). Membrane depolarization fails to evoke calcium release in muscle cells lacking RyR1, demonstrating an essential role for this isoform in excitation-contraction coupling. In contrast, the role of RyR3 is unknown. We studied the participation of RyR3 in calcium release in wild type (containing both RyR1 and RyR3 isoforms) and RyR3/ (containing only RyR1) myotubes in the presence or absence of imperatoxin A (IpTxa), a high-affinity agonist of ryanodine receptors. IpTxa significantly increased the amplitude and the rate of release only in wild-type myotubes. Calcium currents, recorded simultaneously with the transients, were not altered with IpTxa treatment. [³H]ryanodine binding to RyR1 or RyR3 was significantly increased in the presence of IpTxa. Additionally, IpTxa modified the gating and conductance level of single RyR1 or RyR3 channels when studied in lipid bilayers. Our data show that IpTxa can interact with both RyRs and that RyR3 is functional in myotubes and it can amplify the calcium release signal initiated by RyR1, perhaps through a calcium-induced mechanism. In addition, our data indicate that when RyR3/ myotubes are voltage-clamped, the effect of IpTxa is not detected because RyR1s are under the control of the dihydropyridine receptor.

Biophys J, March 2002, p. 1319-1328, Vol. 82, No. 3
© 2002 by the Biophysical Society   0006-3495/02/03/1319/10  $2.00

This article has been cited by other articles:

				J. Zhou, J. Yi, L. Royer, B. S. Launikonis, A. Gonzalez, J. Garcia, and E. Rios A probable role of dihydropyridine receptors in repression of Ca2+ sparks demonstrated in cultured mammalian muscle Am J Physiol Cell Physiol, February 1, 2006; 290(2): C539 - C553. [Abstract] [Full Text] [PDF]

				H. Szappanos, S. Smida-Rezgui, J. Cseri, C. Simut, J.-M. Sabatier, M. De Waard, L. Kovacs, L. Csernoch, and M. Ronjat Differential effects of maurocalcine on Ca2+ release events and depolarization-induced Ca2+ release in rat skeletal muscle J. Physiol., June 15, 2005; 565(3): 843 - 853. [Abstract] [Full Text] [PDF]

				L. Chen, E. Esteve, J.-M. Sabatier, M. Ronjat, M. De Waard, P. D. Allen, and I. N. Pessah Maurocalcine and Peptide A Stabilize Distinct Subconductance States of Ryanodine Receptor Type 1, Revealing a Proportional Gating Mechanism J. Biol. Chem., April 25, 2003; 278(18): 16095 - 16106. [Abstract] [Full Text] [PDF]

				K. J. Alden and J. Garcia Dissociation of charge movement from calcium release and calcium current in skeletal myotubes by gabapentin Am J Physiol Cell Physiol, September 1, 2002; 283(3): C941 - C949. [Abstract] [Full Text] [PDF]